000			01363 a2200373 4500
005			20250515032644.0
264		0	_c20060728
008			200607s 0 0 eng d
022			_a1558-3597
024	7		_a10.1016/j.jacc.2006.04.017 _2doi
040			_aNLM _beng _cNLM
100	1		_aHaga, Susanne B
245	0	0	_aPrescribing BiDil: is it black and white? _h[electronic resource]
260			_bJournal of the American College of Cardiology _cJul 2006
300			_a12-4 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use
650	0	4	_aBlack People
650	0	4	_aDrug Approval
650	0	4	_aDrug Combinations
650	0	4	_aEnalapril _xtherapeutic use
650	0	4	_aHeart Failure _xdrug therapy
650	0	4	_aHumans
650	0	4	_aHydralazine _xtherapeutic use
650	0	4	_aIsosorbide Dinitrate _xtherapeutic use
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States
650	0	4	_aUnited States Food and Drug Administration
650	0	4	_aWhite People
650	0	4	_aBlack or African American
700	1		_aGinsburg, Geoffrey S
773	0		_tJournal of the American College of Cardiology _gvol. 48 _gno. 1 _gp. 12-4
856	4	0	_uhttps://doi.org/10.1016/j.jacc.2006.04.017 _zAvailable from publisher's website
999			_c16407148 _d16407148